HIGHLIGHTS
- who: Dihia Meghnem from the , CNRS, CRCI NA, France, LabEX IGO, Immuno-Onco-Greffe, France, have published the article: Selective Targeting of IL-15Ru03b1 Is Sufficient to Reduce Inflammation, in the Journal: (JOURNAL)
- what: The authors hypothesized that retaining the binding to IL-15Ra while not recruiting IL-2Rb would block IL-15`s signaling through the trimeric IL-15Ra/IL-2Rb/gc receptor without affecting the one through the dimeric IL-2Rb/gc receptor. The authors characterized the inhibitory properties of NANTIL-15 in_vitro. This study provides evidence that selective targeting IL-15Ra chain . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.